Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-017926
Filing Date
2023-05-04
Accepted
2023-05-04 16:29:10
Documents
60
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nuvb-20230331.htm   iXBRL 10-Q 2607071
2 EX-10.1 nuvb-ex10_1.htm EX-10 35449
3 EX-31.1 nuvb-ex31_1.htm EX-31 21429
4 EX-31.2 nuvb-ex31_2.htm EX-31 21512
5 EX-32.1 nuvb-ex32_1.htm EX-32 11252
6 EX-32.2 nuvb-ex32_2.htm EX-32 9622
  Complete submission text file 0000950170-23-017926.txt   10003338

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nuvb-20230331_def.xml EX-101.DEF 175051
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nuvb-20230331_cal.xml EX-101.CAL 51524
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nuvb-20230331_pre.xml EX-101.PRE 297679
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nuvb-20230331_lab.xml EX-101.LAB 398026
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nuvb-20230331.xsd EX-101.SCH 48905
54 EXTRACTED XBRL INSTANCE DOCUMENT nuvb-20230331_htm.xml XML 2398404
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39351 | Film No.: 23889227
SIC: 2834 Pharmaceutical Preparations